GMO rescue of American chestnut tree may take longer than anticipated

American chestnut allen breed ap

The nearly century-old effort to employ selective breeding to rescue the American chestnut, which has been rendered functionally extinct by an introduced disease — Chestnut blight, eventually will succeed, but it will take longer than many people expect.

That is the gist of findings from a new study conducted by a research team composed of scientists from Penn State, The American Chestnut Foundation and State University of New York. This
research should tamp down expectations of both the public and some members of the science community that victory is imminent, but it also provides reassurance that the rescue ultimately will

young chestnuts after innoculation
Transgenic chestnuts in the middle, or B row, expressing the oxalate oxidase transgene, show no signs of wilting.

result in chestnuts flourishing in forests again, according to lead author Kim Steiner, professor of forest biology, Penn State College of Agricultural Sciences.

To reach their conclusions, researchers reviewed and evaluated decades of breeding records and transgenic experiments, new experimental data, and made projections related to how recurrent selection and incorporation of transgenic material into breeding lines will expedite blight resistance. They considered experimentally based estimates of heritability and genetic gain for blight resistance that were never available before this research was conducted.

The GLP aggregated and excerpted this blog/article to reflect the diversity of news, opinion, and analysis. Read full, original post: American chestnut rescue will succeed, but slower than expected

Related Articles

Infographic: Global regulatory and health research agencies on whether glyphosate causes cancer

Infographic: Global regulatory and health research agencies on whether glyphosate causes cancer

Does glyphosate—the world's most heavily-used herbicide—pose serious harm to humans? Is it carcinogenic? Those issues are of both legal and ...

Most Popular

ChatGPT-Image-Mar-10-2026-01_39_01-PM
Viewpoint—“Miracle molecule” debunked: Why acemannan supplements don’t work
Screenshot-2026-09-28-at-2.41.21-PM
Viewpoint: 7-OH controversy: An opioid is available over-the-counter–even at gas stations. Should we be concerned?
Screenshot-2026-09-24-at-3.25.18-PM
No, organic eggs are not more nutritious or necessarily healthier than regular eggs. They are far more expensive.
Screenshot-2026-09-17-at-1.07.08-PM
'We are dangerously addicted to antidepressants': Should we heed RFK Jr.’s sobering warning?
ChatGPT-Image-Sep-25-2026-11_36_56-AM
Now AI almost started a war with China
ChatGPT-Image-Sep-2-2026-02_03_32-PM
How much of a problem is AI’s water use?
ChatGPT-Image-Sep-25-2026-10_36_43-AM
New federal autism committee head has financial ties to leucovorin
ChatGPT-Image-Sep-25-2026-11_57_15-AM
RFK, Jr. likely violated federal ethics guidelines in accepting more than $4,275,000 in gifts and book advances from MAHA allies
ChatGPT-Image-Sep-22-2026-11_17_31-AM
The exploding controversy over AI’s built-in survival drive
Screenshot-2026-09-16-at-10.27.33-AM
Viewpoint: SCOTUS poised to address First Amendment tension between mandatory vaccines, children’s health and religious freedom 
ChatGPT-Image-Sep-27-2026-10_00_17-AM
Current and future RFK Jr. aides criticize his science-rejectionist vaccine views
glp menu logo outlined

Get news on human & agricultural genetics and biotechnology delivered to your inbox.